Clinical Trial

The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial Hypotension

Study acronym: GA-21
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated March 14, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The present study investigates the involvement of the gut hormone glucose-dependent insulinotropic polypeptide (GIP) in the pathophysiology of postprandial hypotension (PPH)
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-05; most recent amendment 2025-03-11.
Status change: Recruiting → Enrolling by Invitation 2025-03-11
Status change: Not Yet Recruiting → Recruiting 2024-02-07
Trial Details
NCT Number NCT06208904
Lead Sponsor University Hospital, Gentofte, Copenhagen
Conditions PostPrandial Hypotension
Enrollment 18 participants
Start Date 2024-05-15
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-14